Program
International Congress of 50th Anniversary KAAACI
(Beyond the 50 years into New Horizons for Asthma and Allergy)
| Day 1 (May 6, Friday) | Day 2 (May 7, Saturday) | ||
| 08:20-08:40 | Registration | 08:00-09:00 | Oral presentation I, II, III, IV |
| 08:40-09:00 | Opening Ceremony | 09:00-09:10 | Break |
| 09:00-10:00 | Plenary Lecture I. Asthma care | 09:10-10:40 |
Symposium V. KAAACI-AAAAI Symposium. Drug allergy |
| 10:00-10:20 | Coffee Break |
Symposium VI. KAAACI-WAO Symposium. Molecular biology |
|
| 10:20-11:50 |
Symposium I. KAAACI-Interasma(North-Asia Chapter)-WPAS Symposium. Asthma comorbidity |
10:40-10:50 | Coffee break |
|
Symposium II. KAAACI-APAAACI Symposium. Updated management of chronic rhinosinusitis (CRS) |
10:50-11:50 | Featured abstracts - Oral presentation V, VI | |
| 11:50-12:00 | Break | 11:50-12:00 | Break |
| 12:00-13:00 |
Plenary Lecture II. Aspirin-exacerbated respiratory diseases |
12:00-12:40 |
Luncheon Symposium III. Novartis |
| 13:00-13:10 | Break |
Luncheon Symposium IV. AstraZeneca (virtual) |
|
| 13:10-13:50 |
Luncheon Symposium I. GSK (virtual) |
12:40-13:00 | Break |
|
Luncheon Symposium II. Sanofi (virtual) |
13:00-14:30 |
Symposium VII. KAAACI-EAAS Symposium. Therapeutics in the spotlight for skin diseases |
|
| 13:50-14:00 | Coffee break |
Symposium VIII. KAAACI-KATRD Symposium. Environment and lung diseases |
|
| 14:00-15:20 | Young Researchers Forum: Preparing the next 50 years | 14:30-14:40 | Break |
| 15:20-15:40 | Break | 14:40-15:20 |
Pros and Cons I (Korean) Endotyping is the answer in the treatment of CRS |
| 15:40-17:10 |
Symposium III. KAAACI-EAACI Symposium. Severe asthma |
Pros and Cons II (Korean) 'As-needed ICS-formoterol' is the best therapy for mild asthma |
|
|
Symposium IV. KAAACI-KAPARD Symposium. Food allergy |
15:20-15:30 | Break | |
| 17:10-17:20 | Break | 15:30-16:30 |
Plenary Lecture III. Potential novel approaches in allergy |
| 17:20-18:00 | Dinner Symposium. Hanmi | 16:30-16:40 | Break |
| 18:00-20:00 | 50th Anniversary Ceremony of KAAACI, KAAACI Award Ceremony |
16:40-17:40 |
Plenary Lecture IV. Planetary health |
17:40-18:00 | Closing |
International Congress of 50th Anniversary KAAACI
(Beyond the 50 years into New Horizons for Asthma and Allergy)
| Day 1 (May 6, Friday) | ||
| 08:20-08:40 | Registration | |
| 08:40-09:00 | Opening Ceremony | |
| 09:00-10:20 | Plenary Lecture I. Asthma care | |
| 1. Global strategy for asthma management and prevention | Louis-Philippe Boulet (Canada) | |
| 2. Asthma in the elderly: Pitfalls and Challenges | Sangheon Cho (Korea) | |
| 10:00-10:20 | Coffee Break | |
| 10:20-11:50 | Symposium I. KAAACI-Interasma(North-Asia Chapter) Symposium. Asthma comorbidity | |
| 1. Evaluation of interaction between allergic rhinitis and asthma | Louis-Philippe Boulet (Canada) | |
| 2. Description of interaction of asthma, obesity, and gastroesophageal reflux disease (virtual) | Ken Ohta (Japan) | |
| 3. Atopic march from atopic dermatitis to asthma | Soo-Jong Hong (Korea) | |
| Symposium II. KAAACI-APAAACI Symposium. Updated management of chronic rhinosinusitis (CRS) | ||
| 1. Phenotypes and endotypes of CRS (virtual) | Luo Zhang (China) | |
| 2. Air pollution and its impact on CRS | Dong-Young Kim (Korea) | |
| 3. Biologics in the management of CRS with nasal polyp (virtual) | Ruby Pawankar (Japan) | |
| 11:50-12:00 | Break | |
| 12:00-13:00 | Plenary Lecture II. Aspirin-exacerbated respiratory diseases | |
| 1. Integrative knowledge on the pathogenesis of AERD | Hae-Sim Park (Korea) | |
| 2. Future perspectives of the treatment for patients with AERD (virtual) | Tanya Laidlaw (USA) | |
| 13:00-13:10 | Break | |
| 13:10-13:50 | Luncheon Symposium I. GSK (virtual) | |
| Inhaled corticosteroids: Understanding therapeutic index | Dave Singh (UK) | |
| Luncheon Symposium II. Sanofi (virtual) | ||
| The role and contribution of IL-4/IL-13 to severe asthma and as a target for treatment | William Busse (USA) | |
| 13:50-14:00 | Coffee break | |
| 14:00-15:20 | Young Researchers Forum I. Preparing the next 50 years | |
| Forum I | ||
| 1. The first step to airway disease, especially non-Type2 asthma | Hye Jung Park (Korea) | |
| 2. Gut-lung axis in adult asthma | Han-Ki Park (Korea) | |
| 3. Early detection of acute mild exacerbation of asthma | So-Young Park (Korea) | |
| 4. Epithelial barrier in respiratory inflammation | Hyun Woo Shin (Korea) | |
| Forum II. | ||
| 1. Korean-specific plant food allergens: Perilla seed story | Kyunguk Jeong (Korea) | |
| 2. Phenotypes of atopic dermatitis according to the natural course in children | Eun Lee (Korea) | |
| 3. Patients-tailored management in contrast media hypersensitivity | Suh-Young Lee (Korea) | |
| 4. The role of regulatory T cells in atopic dermatitis | Hyun Je Kim (Korea) | |
| 15:20-15:40 | Break | |
| 15:40-17:10 | Symposium III. KAAACI-EAACI Symposium. Severe asthma | |
| 1. Pathogenesis and pathophysiology of severe asthma (virtual) | Cezmi Akdis (Switzerland) | |
| 2. EAACI biologicals guidelines-recommendations for severe asthma | Ioana Agache (Romania) | |
| 3. Unsolved issues of severe asthma in an era of biologics | You Sook Cho (Korea) | |
| Symposium IV. KAAACI-KAPARD Symposium. Food allergy | ||
| 1. Development and prevention in food allergy | Jeong Hee Kim (Korea) | |
| 2. Management of food allergy: Present and future | Kangmo Ahn (Korea) | |
| 3. Strategies for research and education of food allergy | Sooyoung Lee (Korea) | |
| 17:10-17:20 | Break | |
| 17:20-18:00 | Dinner Symposium. Hanmi | |
| Efficacy and safety of combined treatment with LTRA & anti-histamine: Monterizine for allergic rhinitis with asthma | Min-Hye Kim (Korea) | |
| 18:00-20:00 | 50th Anniversary Ceremony of KAAACI, KAAACI Award Ceremony | |
International Congress of 50th Anniversary KAAACI
(Beyond the 50 years into New Horizons for Asthma and Allergy)
| Day 2 (May 7, Saturday) | ||||
| 08:00-09:00 | Oral Presentation I | |||
| Oral Presentation II | ||||
| Oral Presentation III | ||||
| Oral Presentation IV | ||||
| 09:00-09:10 | Coffee Break | |||
| 09:10-10:40 | Symposium V. KAAACI-AAAAI Symposium. Drug allergy | |||
| 1. Hypersensitivity to antineoplastic agents | David In-Chull Hong (USA) | |||
| 2. Cephalosporin allergy: Current understanding and future challenges | David Khan (USA) | |||
| 3. Severe cutaneous adverse reactions: A nationwide registry-based study in Korea | Hye-Ryun Kang (Korea) | |||
| Symposium VI. KAAACI-WAO Symposium. Molecular biology | ||||
| 1. New findings of pathophysiology in pollen-food allergy syndrome (virtual) | Ebisawa Motohiro (Japan) | |||
| 2. Novel components to diagnose food allergy (virtual) | Nobuyuki Maruyama (Japan) | |||
| 3. Immunotherapy in patients with pollen allergy | Jung-Won Park (Korea) | |||
| 10:40-10:50 | Coffee Break | |||
| 10:50-11:50 | Featured Abstracts | |||
| Oral Presentation V | ||||
| Oral Presentation VI | ||||
| 11:50-12:00 | Break | |||
| 12:00-12:40 | Luncheon Symposium III. .Novartis | |||
| Omalizumab as the first biologics for severe asthma and CRSwNP | Jae-Hyun Lee (Korea) | |||
| Luncheon Symposium IV. AstraZeneca (virtual) | ||||
| Optimal approach for the treatment of severe asthma: Benralizumab | Andrea Matucci (Italy) | |||
| 12:40-13:00 | Break | |||
| 13:00-14:30 | Symposium VII. KAAACI-EAAS Symposium. Therapeutics in the spotlight for skin diseases | |||
| 1. Insights into chronic urticaria for diagnosis and management (virtual) | Michihiro Hide (Japan) | |||
| 2. The international WAO/EAACI guideline for the management of hereditary angioedema (virtual) | Yuxiang Zhi (China) | |||
| 3. Current and emerging biologics for the treatment of atopic dermatitis | Dong Hun Lee (Korea) | |||
| Symposium VIII. KAAACI-KATRD Symposium. Environment and lung diseases | ||||
| 1. PM & asthma exacerbation: How to measure personal exposure? | Dae Jin Song (Korea) | |||
| 2. Impact of PM on the respiratory system and the effective strategy to avoid its exposure | Sei Won Lee (Korea) | |||
| 3. Toxic inhalation and asthma: Lessons from humidifier disinfectant | Jongin Lee (Korea) | |||
| 4. Environmental and genetic factors in COPD | Woo Jin Kim (Korea) | |||
| 14:30-14:40 | Break | |||
| 14:40-15:20 | Pros and Cons I (Korean) | Pros and Cons II (Korean) | ||
| Endotyping is the answer in the treatment of CRS? | 'As-needed ICS-formoterol' is the best therapy for mild asthma? | |||
| Pros : Ji-Hun Mo (Korea) | Pros : Joo-Hee Kim (Korea) | |||
| Cons : Dae Woo Kim (Korea) | Cons : Jae-Woo Kwon (Korea) | |||
| 15:20-15:30 | Break | |||
| 15:30-16:30 | Plenary Lecture III. Potential novel approaches in allergy | |||
| 1. Novel therapeutics harnessing microbial extracellular vesicles in allergic diseases | Yoon-Keun Kim (Korea) | |||
| 2. Concept of One Health for allergy and asthma | Ioana Agache (Romania | |||
| 16:30-16:40 | Break | |||
| 16:40-17:40 | Plenary Lecture IV. Planetary health | |||
| 1. Climate change and pollen allergy | Jae-Won Oh (Korea) | |||
| 2. Updated ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines (virtual) | Marek Jutel (Poland) | |||
| 17:50-18:00 | Closing | |||
2022 Allied Health Professional (AHP) Symposium
- 일시: 2022년 5월 6일(금) 10:00~22:00
- 진행방식: 온라인 VOD 강의 (총 150분)
- 춘계학회 온라인 플랫폼 내에서 학술대회와 별도로 VOD 링크 연결
- 출결 데이터로 참석 확인
- 진행방식: 온라인 VOD 강의 (총 150분)
- 춘계학회 온라인 플랫폼 내에서 학술대회와 별도로 VOD 링크 연결
- 출결 데이터로 참석 확인
| 강의소요시간 | 강의제목 | 강사 |
| 25분 강의 | 1. 알레르기 피부시험의 실제 | 신유섭(아주의대 내과) |
| 25분 강의 | 2. 알레르기 혈액검사의 실제 | 이용원(가톨릭관동의대 내과) |
| 25분 강의 | 3. 폐기능/기관지유발/FeNO 검사의 실제 | 이상민(가천의대 내과) |
| 25분 강의 | 4. 코통기도검사의 실제 | 송기재(가톨릭관동의대 이비인후과) |
| 25분 강의 | 5. 천식 흡입제 사용법 교육의 실제 | 지혜미(차의대 소아청소년과) |
| 25분 강의 | 6. 알레르기 면역치료의 실제 | 김성렬(연세의대 내과) |